Quotes for Aptahem AB
Right Now
- +/-
- %
- Latest
- High
- Low
- Volume
- Turnover ()
- Time (Latest trade)
Board
CEO
- Mikael Lindstam
Chairperson of the Board
- Bert Junno
Board
- Åsa Kornfeld
- Cristina Glad
- Jan Nilsson
- Johan Lindh
- Theresa Comiskey Olsen
Aptahem is active within biotechnology. The company conducts research and development of aptamer-based pharmaceuticals for the treatment of acute conditions caused by sepsis, blockage of blood vessels, stroke, and heart failure. Through early treatment, the pharmaceutical is intended to prevent damage to organs and tissue. A large part of the research is carried out in collaboration with partners within the industry. The company was founded in 2014 and is based in Malmö.
CEO
Chairperson of the Board
Board
Name | Capital % | Votes % | Date |
---|---|---|---|
Avanza Pension | 9,11 | 9,11 | 2024-03-26 |
Ivar Nordqvist | 7,21 | 7,21 | 2024-03-26 |
Tuvedalen Ltd | 4,90 | 4,90 | 2024-03-26 |
Gunvald Berger | 3,85 | 3,85 | 2024-03-26 |
Nordnet Pensionsförsäkring | 1,82 | 1,82 | 2024-03-26 |
Folke Harry Gerhard Ebbesson | 1,34 | 1,34 | 2024-03-26 |
AB Svedala Finans | 1,23 | 1,23 | 2024-03-26 |
Christian Pettersson | 1,01 | 1,01 | 2024-03-26 |
Lövenblads Holding AB | 0,94 | 0,94 | 2024-03-26 |
Tomas Adolfsson | 0,79 | 0,79 | 2024-03-26 |
2024-05-15 Årsstämma 2023
2024-05-31 Delårsrapport 2024-Q1